Last reviewed · How we verify

Bupivacaine-fentanyl — Competitive Intelligence Brief

Bupivacaine-fentanyl (Bupivacaine-fentanyl) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic-opioid combination. Area: Anesthesia and Pain Management.

marketed Local anesthetic-opioid combination Voltage-gated sodium channels (bupivacaine); mu-opioid receptor (fentanyl) Anesthesia and Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Bupivacaine-fentanyl (Bupivacaine-fentanyl) — Abdelrady S Ibrahim, MD. Bupivacaine-fentanyl is a combination of a local anesthetic and an opioid analgesic that blocks nerve conduction and provides pain relief through multiple mechanisms.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Bupivacaine-fentanyl TARGET Bupivacaine-fentanyl Abdelrady S Ibrahim, MD marketed Local anesthetic-opioid combination Voltage-gated sodium channels (bupivacaine); mu-opioid receptor (fentanyl)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic-opioid combination class)

  1. Abdelrady S Ibrahim, MD · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Bupivacaine-fentanyl — Competitive Intelligence Brief. https://druglandscape.com/ci/bupivacaine-fentanyl. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: